3-156548985-C-T
Position:
Variant summary
Our verdict is Benign. Variant got -19 ACMG points: 0P and 19B. BP4_ModerateBP6_Very_StrongBP7BA1
The NM_007107.5(SSR3):c.279G>A(p.Glu93Glu) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.134 in 1,612,430 control chromosomes in the GnomAD database, including 15,127 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.14 ( 1554 hom., cov: 33)
Exomes 𝑓: 0.13 ( 13573 hom. )
Consequence
SSR3
NM_007107.5 synonymous
NM_007107.5 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: 0.885
Genes affected
SSR3 (HGNC:11325): (signal sequence receptor subunit 3) The signal sequence receptor (SSR) is a glycosylated endoplasmic reticulum (ER) membrane receptor associated with protein translocation across the ER membrane. The SSR is comprised of four membrane proteins/subunits: alpha, beta, gamma, and delta. The first two are glycosylated subunits and the latter two are non-glycosylated subunits. This gene encodes the gamma subunit, which is predicted to span the membrane four times. [provided by RefSeq, Aug 2010]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -19 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.27).
BP6
Variant 3-156548985-C-T is Benign according to our data. Variant chr3-156548985-C-T is described in ClinVar as [Benign]. Clinvar id is 1537157.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=0.885 with no splicing effect.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.203 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SSR3 | NM_007107.5 | c.279G>A | p.Glu93Glu | synonymous_variant | 3/5 | ENST00000265044.7 | NP_009038.1 | |
SSR3 | NM_001308197.2 | c.279G>A | p.Glu93Glu | synonymous_variant | 3/5 | NP_001295126.1 | ||
SSR3 | NM_001308204.2 | c.123G>A | p.Glu41Glu | synonymous_variant | 3/5 | NP_001295133.1 | ||
SSR3 | NM_001308205.2 | c.123G>A | p.Glu41Glu | synonymous_variant | 3/5 | NP_001295134.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.140 AC: 21269AN: 151996Hom.: 1540 Cov.: 33
GnomAD3 genomes
AF:
AC:
21269
AN:
151996
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.146 AC: 36555AN: 250206Hom.: 2871 AF XY: 0.147 AC XY: 19841AN XY: 135360
GnomAD3 exomes
AF:
AC:
36555
AN:
250206
Hom.:
AF XY:
AC XY:
19841
AN XY:
135360
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.133 AC: 194146AN: 1460314Hom.: 13573 Cov.: 36 AF XY: 0.134 AC XY: 97253AN XY: 726516
GnomAD4 exome
AF:
AC:
194146
AN:
1460314
Hom.:
Cov.:
36
AF XY:
AC XY:
97253
AN XY:
726516
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.140 AC: 21315AN: 152116Hom.: 1554 Cov.: 33 AF XY: 0.141 AC XY: 10494AN XY: 74354
GnomAD4 genome
AF:
AC:
21315
AN:
152116
Hom.:
Cov.:
33
AF XY:
AC XY:
10494
AN XY:
74354
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
828
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Feb 02, 2025 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at